Smartphone-based iontophoresis transdermal drug delivery system for cancer treatment.

Cancer is a leading cause of the death worldwide. However, the conventional cancer therapy still suffers from several limitations, such as systemic side effects, poor efficacy, and patient compliance due to limited accessibility to the tumor site. To address these issues, the localized drug delivery system has emerged as a promising approach. In this study, we developed an iontophoresis-based transdermal drug delivery system (TDDS) controlled by a smartphone application for cancer treatment. Iontophoresis, a low-intensity electric current-based TDDS, enhances drug permeation across the skin to provide potential for localized drug delivery and minimize systemic side effects. The fundamental mechanism of our system was modeled using finite element analysis and its performance was corroborated through the flow-through skin permeation tests using a plastic-based microfluidic chip. The results of in vitro cell experiments and skin deposition tests successfully demonstrated that our smartphone-controlled iontophoresis system significantly enhanced the drug permeation for cancer treatment. Therefore, this hand-held smartphone-based iontophoresis TDDS could be a powerful tool for self-administrated anticancer drug delivery applications. [Display omitted] • We developed the smartphone-based skin permeation plastic iontophoresis device to administer anticancer drugs. • The doxorubicin released from smartphone-based iontophoresis without microneedles was deeply penetrated into tumor sites. • We can rapidly interrupt anticancer drug permeation that reduces the symptoms of side effects at an early stage. [ABSTRACT FROM AUTHOR]